Table 2 Differences between with Survival group and the Death group (univariate analysis)
From: A dynamic online nomogram for predicting death in hospital after aneurysmal subarachnoid hemorrhage
Variable | Development cohort (n = 687) | Validation cohort (n = 299) | ||||
|---|---|---|---|---|---|---|
Survival group (n = 615) | Death group (n = 72) | p value | Survival group (n = 268) | Death group (n = 31) | p value | |
Sex | 241 (39.19%) | 24 (33.33%) | 0.402 | 100 (37.31%) | 17 (54.84%) | 0.089 |
Age | 58 (50–65) | 59.5 (53.5–65) | 0.202 | 60 (51–66) | 64 (55–66) | 0.127 |
Level on GCS score |  |  |  < 0.001 |  |  |  < 0.001 |
 Mild (13–15 score) | 428 (69.59%) | 27 (37.50%) |  | 138 (51.49%) | 5 (16.13%) |  |
 Moderate (9–12 score) | 83 (13.50%) | 11 (15.28%) |  | 67 (25.00%) | 5 (16.13%) |  |
 Severe (3–8 score) | 104 (16.91%) | 34 (47.22%) |  | 63 (23.51%) | 21 (67.74%) |  |
 MAP, mmHg | 135.33 (120.00–151.33) | 144.33 (124.83–156.67) | 0.035 | 110.67 (101.25–123.33) | 113.33 (102.33–130.33) | 0.429 |
 Hypertension | 235 (38.21%) | 35 (48.61%) | 0.058 | 136 (50.78%) | 14 (45.16%) | 0.690 |
 Diabetes | 41 (6.67%) | 8 (11.11%) | 0.252 | 15 (5.60%) | 4 (12.90%) | 0.120 |
Hunt–Hess grade |  |  |  < 0.001 |  |  |  < 0.001 |
 I | 128 (20.81%) | 9 (12.50%) |  | 41 (15.30%) | 1 (3.23%) |  |
 II | 124 (20.16%) | 7 (9.72%) |  | 82 (30.60%) | 3 (9.68%) |  |
 III | 247 (40.16%) | 19 (26.39%) |  | 85 (31.72%) | 5 (16.13%) |  |
 IV | 102 (16.59%) | 28 (38.89%) |  | 49 (18.28%) | 14 (45.16%) |  |
 V | 14 (2.28%) | 9 (12.50%) |  | 11 (4.10%) | 8 (25.81%) |  |
mFS grade |  |  |  < 0.001 |  |  |  < 0.029 |
 0 | 3 (0.49%) | 0 (0.00%) |  | 3 (1.12%) | 1 (3.23%) |  |
 I | 101 (16.42%) | 6 (8.33%) |  | 24 (8.96%) | 0 (0%) |  |
 II | 323 (52.52%) | 24 (33.33%) |  | 40 (14.93%) | 4 (12.90%) |  |
 III | 110 (17.89%) | 28 (38.89%) |  | 66 (24.63%) | 15 (48.39%) |  |
 IV | 78 (12.68%) | 14 (19.44%) |  | 135 (50.37%) | 11 (35.48%) |  |
NIHSS score | 2 (0–9) | 24.5 (2–35) |  < 0.001 | 3 (1, 8) | 26 (7, 35.5) |  < 0.001 |
Smoking | 43 (7.15%) | 1 (1.39%) | 0.074 | 21 (7.84%) | 1 (3.23%) | 0.197 |
Drink abuse | 33 (5.37%) | 1 (1.39%) | 0.244 | 21 (7.84%) | 1 (3.23%) | 0.197 |
Blood glucose | 8.20 (6.90–10.34) | 10.70 (8.31–13.17) |  < 0.001 | 8.52 (7.12–10.29) | 10.85 (8.67–16.24) |  < 0.001 |
Serum calcium level | 2.27 (2.18–2.35) | 2.30 (2.19–2.39) | 0.205 | 2.17 (2.08–2.24) | 2.17 (2.08–2.24) | 0.880 |
Leukocyte count | 13.34 (10.31–16.50) | 16.93 (14.46–20.91) |  < 0.001 | 13.09 (10.23–16.05) | 17.94 (15.79–21.14) |  < 0.001 |
Neutrophil count | 11.12 (8.04–14.24) | 14.31 (12.31–18.64) |  < 0.001 | 10.82 (7.89–13.61) | 14.08 (11.78–18.57) |  < 0.001 |
Lymphocyte count | 1.35 (0.92–1.98) | 1.42 (0.86–2.14) | 0.949 | 1.58 (0.94–2.26) | 1.71 (1.37–2.60) | 0.102 |
Monocyte count | 0.54 (0.36–0.76) | 0.72 (0.52–0.98) |  < 0.001 | 0.59 (0.41–0.80) | 1.39 (0.90–1.63) |  < 0.001 |
Platelet count | 235 (197–275) | 243 (196.5–271) | 0.498 | 239.50 (199–291.50) | 239 (211–257.50) | 0.577 |
NLR | 8.53 (4.84–13.63) | 12.63 (6.15–17.20) | 0.003 | 7.24 (3.76–12.04) | 9.02 (4.14–12.00) | 0.636 |
MLR | 0.38 (0.25–0.55) | 0.56 (0.32–0.81) |  < 0.001 | 0.38 (0.24–0.60) | 0.88 (0.33–1.30) |  < 0.001 |
PLR | 168.21 (118.11–251.57) | 172.37 (103.88–265.11) | 0.852 | 153.36 (105.22–241.01) | 139.34 (89.65–179.16) | 0.060 |
NWR | 0.85 (0.77–0.9) | 0.87 (0.81–0.9) | 0.044 | 0.82 (0.73–0.89) | 0.80 (0.73–0.86) | 0.207 |
MNM | 5.35 (3.11–9.35) | 10.58 (6.58–16.66) |  < 0.001 | 6.19 (3.50–10.17) | 21.44 (12.71–25.97) |  < 0.001 |